Recurrent cytogenetic aberrations in human ovarian carcinomas
- PMID: 7750111
Recurrent cytogenetic aberrations in human ovarian carcinomas
Abstract
Successful cytogenetic analysis was performed on short-term cultures of 62 malignant ovarian tumors from 42 patients. Twenty-three tumors from 18 patients revealed clonal chromosome abnormalities. Five cases showed nonclonal chromosome changes. In the remaining 19 cases, a normal female karyotype was found. Numerical or single structural changes were found in only 11 carcinomas from nine patients. Trisomy 12 and 7 were each the sole abnormality in two cases a piece. One tumor showed a trisomy 6 as the only karyotypic change. Four tumors revealed simple translocations and deletions affecting the chromosomes X, 1, 2, 6, and 7. Twelve of the cytogenetically abnormal tumor samples showed complex karyotypes with both numerical and structural aberrations leading to hyperdiploid, near-triploid, and near-tetraploid stemlines. The recurrent numerical imbalances were losses of the chromosomes 1 (N = 5), X (N = 3), and 17 (N = 3), and gains of the chromosomes 12 (N = 5) and 20 (N = 3). Regarding structural rearrangements, the chromosome bands 11p13-14 and 19p13 were the most frequently affected regions. 11p13-14 was rearranged in four tumors. In two cases, a deletion 11p13-14 was found. Two tumors revealed a nonreciprocal translocation involving 11p13-14 and leading to the loss of distal 11p material. The most consistent finding was a 19p+ marker chromosome, which was present in five different ovarian carcinomas. Our results are in accordance with a recent cytogenetic report describing a 19p+ marker and loss of 11p material as consistent cytogenetic aberrations in human ovarian carcinomas.
Similar articles
-
Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas.Gynecol Oncol. 1994 Nov;55(2):198-205. doi: 10.1006/gyno.1994.1277. Gynecol Oncol. 1994. PMID: 7959284
-
Chromosome aberrations in 35 primary ovarian carcinomas.Genes Chromosomes Cancer. 1992 Jan;4(1):58-68. doi: 10.1002/gcc.2870040108. Genes Chromosomes Cancer. 1992. PMID: 1377010
-
Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.Cancer Res. 1984 Mar;44(3):1257-64. Cancer Res. 1984. PMID: 6692407
-
Polysomy 8 in three cases of homologous malignant mixed Müllerian tumors of the uterus.Anticancer Res. 2003 Mar-Apr;23(2B):1379-83. Anticancer Res. 2003. PMID: 12820397 Review.
-
Chromosomes in plasma-cell malignancies.Eur J Haematol Suppl. 1989;51:47-51. Eur J Haematol Suppl. 1989. PMID: 2697595 Review.
Cited by
-
Involvement of DPP9 in gene fusions in serous ovarian carcinoma.BMC Cancer. 2017 Sep 11;17(1):642. doi: 10.1186/s12885-017-3625-6. BMC Cancer. 2017. PMID: 28893231 Free PMC article.
-
The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome.PLoS One. 2012;7(9):e45484. doi: 10.1371/journal.pone.0045484. Epub 2012 Sep 20. PLoS One. 2012. PMID: 23029043 Free PMC article.
-
Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity.Proc Natl Acad Sci U S A. 2000 May 9;97(10):5357-62. doi: 10.1073/pnas.090013497. Proc Natl Acad Sci U S A. 2000. PMID: 10805796 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical